Zunilda Silva is a seasoned professional in the pharmaceutical industry, currently serving as the Latina CMO Supply Planning Manager at Haleon. With a robust background that spans various domains, including quality assurance, production, and supply chain management, Zunilda brings a wealth of expertise to her...
Zunilda Silva is a seasoned professional in the pharmaceutical industry, currently serving as the Latina CMO Supply Planning Manager at Haleon. With a robust background that spans various domains, including quality assurance, production, and supply chain management, Zunilda brings a wealth of expertise to her role. Her extensive experience encompasses MRP system implementation, particularly with BPCS, and operational excellence, where she has excelled as both a champion and an expert.
In her current position, Zunilda is pivotal in overseeing supply planning for Latina contract manufacturers, where she leverages her strategic thinking and leadership skills to drive efficiency and optimize logistics management. Her commitment to supply chain optimization is evident in her management of inventory and budget administration, ensuring that resources are allocated effectively to meet production demands. Zunilda is particularly adept at spearheading improvement projects that enhance business processes, making her a key player in Haleon’s operational success.
Her leadership of multidisciplinary teams showcases her ability to foster collaboration and innovation, while her critical thinking skills enable her to navigate complex challenges in the fast-paced pharmaceutical landscape. Zunilda’s proficiency in forecasting and inventory management further solidifies her role as a strategic asset within the organization. As a Latina leader in a predominantly male industry, she not only champions diversity and inclusion but also serves as an inspiration for future generations of professionals in the field. Through her dedication and expertise, Zunilda Silva continues to make significant contributions to Haleon and the broader pharmaceutical community.
